Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5284564> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Q5284564 subject Q8300802.
- Q5284564 subject Q8655434.
- Q5284564 subject Q8883124.
- Q5284564 abstract "The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee, the Medical Research Council, and the pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica, and Pfizer. The purpose of the collaboration is to conduct cell signalling research and to encourage development of new drug treatments for global diseases such as cancer, rheumatoid arthritis, and Parkinson’s Disease. Specifically the collaboration aims to target protein kinases and the ubiquitylation system in the development of these therapies. It is one of the largest ever collaborations between the commercial pharmaceutical industry and any academic research institute.".
- Q5284564 affiliation Q206921.
- Q5284564 affiliation Q212322.
- Q5284564 affiliation Q2779401.
- Q5284564 affiliation Q699532.
- Q5284564 affiliation Q731938.
- Q5284564 affiliation Q903523.
- Q5284564 budget "2750000.0".
- Q5284564 formationYear "1998".
- Q5284564 numberOfStaff "200".
- Q5284564 parentOrganisation Q1249005.
- Q5284564 wikiPageExternalLink dstt.
- Q5284564 wikiPageWikiLink Q11085.
- Q5284564 wikiPageWikiLink Q12078.
- Q5284564 wikiPageWikiLink Q1249005.
- Q5284564 wikiPageWikiLink Q131257.
- Q5284564 wikiPageWikiLink Q145.
- Q5284564 wikiPageWikiLink Q187255.
- Q5284564 wikiPageWikiLink Q206921.
- Q5284564 wikiPageWikiLink Q210973.
- Q5284564 wikiPageWikiLink Q212322.
- Q5284564 wikiPageWikiLink Q2779401.
- Q5284564 wikiPageWikiLink Q407111.
- Q5284564 wikiPageWikiLink Q5222818.
- Q5284564 wikiPageWikiLink Q58321.
- Q5284564 wikiPageWikiLink Q626251.
- Q5284564 wikiPageWikiLink Q699532.
- Q5284564 wikiPageWikiLink Q7183365.
- Q5284564 wikiPageWikiLink Q7251493.
- Q5284564 wikiPageWikiLink Q7269922.
- Q5284564 wikiPageWikiLink Q731938.
- Q5284564 wikiPageWikiLink Q746879.
- Q5284564 wikiPageWikiLink Q7868.
- Q5284564 wikiPageWikiLink Q80976.
- Q5284564 wikiPageWikiLink Q8300802.
- Q5284564 wikiPageWikiLink Q8655434.
- Q5284564 wikiPageWikiLink Q8883124.
- Q5284564 wikiPageWikiLink Q903523.
- Q5284564 wikiPageWikiLink Q9682.
- Q5284564 affiliations "AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica and Pfizer".
- Q5284564 budget "£2.75 million/year".
- Q5284564 formation "1998".
- Q5284564 leaderName "Dario Alessi, Philip Cohen, Ron Hay".
- Q5284564 name "Division of Signal Transduction Therapy".
- Q5284564 numStaff "200".
- Q5284564 parentOrganization Q1249005.
- Q5284564 website dstt.
- Q5284564 type Organization.
- Q5284564 type Agent.
- Q5284564 type Organisation.
- Q5284564 type Agent.
- Q5284564 type SocialPerson.
- Q5284564 type Thing.
- Q5284564 type Q43229.
- Q5284564 comment "The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee, the Medical Research Council, and the pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica, and Pfizer. The purpose of the collaboration is to conduct cell signalling research and to encourage development of new drug treatments for global diseases such as cancer, rheumatoid arthritis, and Parkinson’s Disease.".
- Q5284564 label "Division of Signal Transduction Therapy".
- Q5284564 homepage dstt.
- Q5284564 name "Division of Signal Transduction Therapy".